Pharmacologic interventions

Renata Yang, Marian Fireman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pharmacologic interventions to treat alcohol use in patients with liver disease target symptoms of alcohol withdrawal or are aimed at reducing or eliminating alcohol consumption. Benzodiazepines remain the accepted pharmacologic treatment for alcohol withdrawal, although anticonvulsants may be used for mild-moderate alcohol withdrawal. Disulfiram, naltrexone, and acamprosate are the most widely utilized pharmacologic treatments for alcohol consumption although quite a few other medications have been studied and are prescribed. Use of all of these medications in the face of liver disease requires careful choice to avoid hepatotoxicity. In all cases, patients should receive a thorough evaluation. Risks versus benefits must be considered in each individual patient and concurrent psychosocial treatment is highly recommended.

Original languageEnglish (US)
Title of host publicationAlcohol Abuse and Liver Disease
PublisherWiley Blackwell
Pages175-185
Number of pages11
ISBN (Electronic)9781118887318
ISBN (Print)9781118887288
DOIs
StatePublished - Jul 31 2015

Fingerprint

Alcohols
Alcohol Drinking
Liver Diseases
Disulfiram
Substance Withdrawal Syndrome
Naltrexone
Benzodiazepines
Anticonvulsants
Therapeutics

Keywords

  • Acamprosate
  • Baclofen
  • Benzodiazepine
  • Carbamazepine
  • Disulfiram
  • Gabapentin
  • Nalmefene
  • Naltrexone
  • Topiramate
  • Valproic acid

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yang, R., & Fireman, M. (2015). Pharmacologic interventions. In Alcohol Abuse and Liver Disease (pp. 175-185). Wiley Blackwell. https://doi.org/10.1002/9781118887318.ch19

Pharmacologic interventions. / Yang, Renata; Fireman, Marian.

Alcohol Abuse and Liver Disease. Wiley Blackwell, 2015. p. 175-185.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yang, R & Fireman, M 2015, Pharmacologic interventions. in Alcohol Abuse and Liver Disease. Wiley Blackwell, pp. 175-185. https://doi.org/10.1002/9781118887318.ch19
Yang R, Fireman M. Pharmacologic interventions. In Alcohol Abuse and Liver Disease. Wiley Blackwell. 2015. p. 175-185 https://doi.org/10.1002/9781118887318.ch19
Yang, Renata ; Fireman, Marian. / Pharmacologic interventions. Alcohol Abuse and Liver Disease. Wiley Blackwell, 2015. pp. 175-185
@inbook{2fede7cc1e9c426eac7338e431c322b0,
title = "Pharmacologic interventions",
abstract = "Pharmacologic interventions to treat alcohol use in patients with liver disease target symptoms of alcohol withdrawal or are aimed at reducing or eliminating alcohol consumption. Benzodiazepines remain the accepted pharmacologic treatment for alcohol withdrawal, although anticonvulsants may be used for mild-moderate alcohol withdrawal. Disulfiram, naltrexone, and acamprosate are the most widely utilized pharmacologic treatments for alcohol consumption although quite a few other medications have been studied and are prescribed. Use of all of these medications in the face of liver disease requires careful choice to avoid hepatotoxicity. In all cases, patients should receive a thorough evaluation. Risks versus benefits must be considered in each individual patient and concurrent psychosocial treatment is highly recommended.",
keywords = "Acamprosate, Baclofen, Benzodiazepine, Carbamazepine, Disulfiram, Gabapentin, Nalmefene, Naltrexone, Topiramate, Valproic acid",
author = "Renata Yang and Marian Fireman",
year = "2015",
month = "7",
day = "31",
doi = "10.1002/9781118887318.ch19",
language = "English (US)",
isbn = "9781118887288",
pages = "175--185",
booktitle = "Alcohol Abuse and Liver Disease",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Pharmacologic interventions

AU - Yang, Renata

AU - Fireman, Marian

PY - 2015/7/31

Y1 - 2015/7/31

N2 - Pharmacologic interventions to treat alcohol use in patients with liver disease target symptoms of alcohol withdrawal or are aimed at reducing or eliminating alcohol consumption. Benzodiazepines remain the accepted pharmacologic treatment for alcohol withdrawal, although anticonvulsants may be used for mild-moderate alcohol withdrawal. Disulfiram, naltrexone, and acamprosate are the most widely utilized pharmacologic treatments for alcohol consumption although quite a few other medications have been studied and are prescribed. Use of all of these medications in the face of liver disease requires careful choice to avoid hepatotoxicity. In all cases, patients should receive a thorough evaluation. Risks versus benefits must be considered in each individual patient and concurrent psychosocial treatment is highly recommended.

AB - Pharmacologic interventions to treat alcohol use in patients with liver disease target symptoms of alcohol withdrawal or are aimed at reducing or eliminating alcohol consumption. Benzodiazepines remain the accepted pharmacologic treatment for alcohol withdrawal, although anticonvulsants may be used for mild-moderate alcohol withdrawal. Disulfiram, naltrexone, and acamprosate are the most widely utilized pharmacologic treatments for alcohol consumption although quite a few other medications have been studied and are prescribed. Use of all of these medications in the face of liver disease requires careful choice to avoid hepatotoxicity. In all cases, patients should receive a thorough evaluation. Risks versus benefits must be considered in each individual patient and concurrent psychosocial treatment is highly recommended.

KW - Acamprosate

KW - Baclofen

KW - Benzodiazepine

KW - Carbamazepine

KW - Disulfiram

KW - Gabapentin

KW - Nalmefene

KW - Naltrexone

KW - Topiramate

KW - Valproic acid

UR - http://www.scopus.com/inward/record.url?scp=85015891712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015891712&partnerID=8YFLogxK

U2 - 10.1002/9781118887318.ch19

DO - 10.1002/9781118887318.ch19

M3 - Chapter

AN - SCOPUS:85015891712

SN - 9781118887288

SP - 175

EP - 185

BT - Alcohol Abuse and Liver Disease

PB - Wiley Blackwell

ER -